Literature DB >> 14522402

Myocarditis and dilated cardiomyopathy: an inflammatory link.

Jay W Mason1.   

Abstract

Myocarditis is a complex disease because multiple pathogenetic mechanisms play a role. While these mechanisms appear to act in a chronological cascade, they undoubtedly overlap in some cases, rendering diagnosis and treatment difficult. Ultimately, dilated cardiomyopathy (DCM) may result. A multitude of still-circumstantial evidence points to a major role of viral myocarditis in the etiology of DCM. The common presence of viral genetic material and viral proteins in the myocardium of patients with DCM provides the most compelling evidence, but proof of causality is still lacking. Nevertheless, because of the striking increase in heart failure prevalence in recent years, anti-viral and anti-inflammatory therapies should be developed for their potential to prevent or ameliorate DCM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522402     DOI: 10.1016/s0008-6363(03)00437-1

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  61 in total

Review 1.  [Treatment of progressive heart failure: pharmacotherapy, resynchronization (CRT), surgery].

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Herz       Date:  2010-03       Impact factor: 1.443

Review 2.  Imaging inflammatory cardiomyopathies.

Authors:  Dominique Le Guludec; Laure Sarda; Francois Rouzet; Pascal Merlet; Michel S Slama; Rachida Lebtahi
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

3.  [Classification of cardiomyopathies and indication for endomyocardial biopsy revisited].

Authors:  Sabine Pankuweit; Anette Richter; Volker Ruppert; Bernhard Maisch
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

4.  Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. against coxsackievirus B3 in mice.

Authors:  Ji Pang; Jin-peng Guo; Min Jin; Zhi-qiang Chen; Xin-wei Wang; Jun-Wen Li
Journal:  Chin J Integr Med       Date:  2011-06-29       Impact factor: 1.978

5.  Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes.

Authors:  Gudrun Szalay; Silke Meiners; Antje Voigt; Jörg Lauber; Christian Spieth; Nora Speer; Martina Sauter; Ulrike Kuckelkorn; Andreas Zell; Karin Klingel; Karl Stangl; Reinhard Kandolf
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 6.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 7.  Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure.

Authors:  Ziya Kaya; Hugo A Katus; Noel R Rose
Journal:  Clin Immunol       Date:  2009-05-14       Impact factor: 3.969

Review 8.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 9.  [Classification, genetic predisposition and risk factors for the development of cardiomyopathies].

Authors:  S Pankuweit; A Richter; V Ruppert; R Funck; B Maisch
Journal:  Internist (Berl)       Date:  2008-04       Impact factor: 0.743

10.  Expression of coxsackievirus and adenovirus receptor and its cellular localization in myocardial tissues of dilated cardiomyopathy.

Authors:  Tripta Kaur; Baijayantimala Mishra; Uma Nahar Saikia; Mirnalini Sharma; Ajay Bahl; Radha Kanta Ratho
Journal:  Exp Clin Cardiol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.